British Charities Respond To Baby Powder Lawsuits

A number of British cancer charities have responded to the Johnson & Johnson's baby powder lawsuits, with agreement across the board that women should avoid using the popular cosmetic because of ovarian cancer concerns.

Wednesday, June 22, 2016 - A number of British cancer charities have recently been weighing in on the talcum powder cancer lawsuits that have been accumulating in the U.S. More than 1,000 Johnson & Johnson's baby powder cancer lawsuits have been filed in the U.S., and the plaintiffs in these lawsuits claim that Johnson & Johnson was aware of the ovarian cancer studies that had been conducted related to their talcum powder products and decided against affixing warning labels to the merchandise. The talcum powder ovarian cancer attorneys representing the plaintiffs have claimed that the health care company negligently put the health of their consumers at risk in ignoring the talcum powder cancer research studies, and that many women may have contracted as a result of this oversight.

The British cancer charities have released these statements in response to two recent talcum powder lawsuit trial awards given to a pair of plaintiffs, which totaled more than $120 million combined. This pushed the news of the Johnson & Johnson's baby powder lawsuits worldwide and caught the attention of governments and cancer-related agencies. One of the British cancer charities that responded to the talcum powder ovarian cancer lawsuit news was Ovarian Cancer Action, which advised women to refrain from using talcum powder on their genital area. Most of the talcum powder ovarian cancer research has focused on women that use talcum powder on their genital area and the impact of using the cosmetic in that fashion on their ovaries.

Another British cancer charity that released a statement was Target Ovarian Cancer, which also asked women to discontinue the use of baby powder as a genital hygienic. A third charity, Ovacome, also weighed in on the talcum powder ovarian cancer lawsuit situation. It took a closer look at the research that has been conducted and claimed that while talcum powder may contribute to ovarian cancer, it is unlikely that it is a one-to-one correlation and that many environmental factors can lead to the development of ovarian cancer.

All the charities pointed out that the research conducted thus far does not create this one-to-one relationship, and that even if the correlation does exist, it does not double or triple the chances of a consumer contracting ovarian cancer. The talcum powder cancer lawyers have produced studies that have found the increased risk of ovarian cancer related to talcum powder to be at much as 33 percent, but that figure did not influence the cancer charities to take a more forceful stance on the relationship between talcum powder and ovarian cancer.

Those figures however did hold sway with the juries that weighed in on the million-dollar awards given to Johnson & Johnson's baby powder cancer lawsuit plaintiffs. The studies, in concert with internal documents recovered from Johnson & Johnson that proved the company had been aware of the talcum powder problem in the early 1990's, convinced the juries for the first two talcum powder cancer lawsuit trials to bestow awards onto the plaintiffs to do so to the tune of $127 million. Though the charities may take the slow approach in acknowledging the possible connection between talcum powder and ovarian cancer, their suggestion that women avoid using the cosmetic genitally speaks to the impact that Johnson & Johnson's baby powder lawsuits are having on agencies worldwide following the story.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.